We are live on
!
Find out more
EARNEST Partners Portfolio holdings
AUM
$24.3B
1-Year Est. Return
34.41%
This Fund
S&P 500
This Quarter
Est. Return
+5.13%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$17.9B
AUM Growth
+$600M
(+3.5%)
Cap. Flow
+$24.4M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
15.34%
Holding
1,185
New
13
Increased
112
Reduced
147
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TriNet
TNET
|
+$101M |
| 2 |
Insperity
NSP
|
+$99.5M |
| 3 |
Helmerich & Payne
HP
|
+$77.1M |
| 4 |
Qiagen
QGEN
|
+$64M |
| 5 |
Sonoco
SON
|
+$42.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$105M |
| 2 |
Canadian National Railway
CNI
|
+$76.6M |
| 3 |
Hexcel
HXL
|
+$65.4M |
| 4 |
SPX Corp
SPXC
|
+$65M |
| 5 |
Meritage Homes
MTH
|
+$61.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.5% |
| 2 | Technology | 20.45% |
| 3 | Financials | 16.44% |
| 4 | Consumer Discretionary | 11.88% |
| 5 | Healthcare | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Allient
ALNT
$1.34B
| $210K | ﹤0.01% |
5,250
| – | – |
|
277
Johnson & Johnson
JNJ
$640B
| $206K | ﹤0.01% |
1,242
| – | – |
|
278
EOG Resources
EOG
$77.7B
| $202K | ﹤0.01% |
1,762
-30
| -2% | -$3.43K |
|
279
Lloyds Banking Group
LYG
$85.2B
| $191K | ﹤0.01% |
87,009
+34,785
| +67% | +$79.8K |
|
280
Constellation Energy
CEG
$92.1B
| $188K | ﹤0.01% |
2,051
-44
| -2% | -$3.65K |
|
281
Eli Lilly
LLY
$1.08T
| $187K | ﹤0.01% |
398
| – | – |
|
282
Visa
V
$701B
| $186K | ﹤0.01% |
783
| – | – |
|
283
iShares MSCI China ETF
MCHI
$6.23B
| $168K | ﹤0.01% |
3,754
| – | – |
|
284
Mastercard
MA
$498B
| $162K | ﹤0.01% |
413
| – | – |
|
285
Broadcom
AVGO
$1.76T
| $161K | ﹤0.01% |
1,860
| – | – |
|
|
ABCM
286
DELISTED
Abcam PLC
ABCM
| $159K | ﹤0.01% |
6,479
| – | – |
|
287
Synchrony
SYF
$24.4B
| $156K | ﹤0.01% |
4,612
-83
| -2% | -$2.53K |
|
288
Home Depot
HD
$337B
| $151K | ﹤0.01% |
487
| – | – |
|
289
Procter & Gamble
PG
$340B
| $149K | ﹤0.01% |
980
| – | – |
|
290
Axos Financial
AX
$5.58B
| $142K | ﹤0.01% |
3,600
| – | – |
|
291
Exelon
EXC
$48.1B
| $138K | ﹤0.01% |
3,396
| – | – |
|
292
Chevron
CVX
$382B
| $138K | ﹤0.01% |
874
| – | – |
|
293
Merck
MRK
$322B
| $137K | ﹤0.01% |
1,183
| – | – |
|
294
VanEck Vietnam ETF
VNM
$478M
| $119K | ﹤0.01% |
8,922
| – | – |
|
295
iShares MSCI India ETF
INDA
$6.81B
| $117K | ﹤0.01% |
2,679
| – | – |
|
|
SYNH
296
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $117K | ﹤0.01% |
2,767
-2,590,741
| -100% | -$105M |
|
297
AbbVie
ABBV
$465B
| $114K | ﹤0.01% |
847
| – | – |
|
|
ZYXI
298
DELISTED
Zynex
ZYXI
| $114K | ﹤0.01% |
11,874
| – | – |
|
299
Salesforce
CRM
$154B
| $113K | ﹤0.01% |
536
| – | – |
|
300
Adobe
ADBE
$105B
| $112K | ﹤0.01% |
230
| – | – |
|
Similar funds
JG
SC
CS
AF
EARNEST Partners's Q2 2023 Portfolio in Review
As of Q2 2023, EARNEST Partners held 1,185 positions worth $17.9B, up 3.5% from $17.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 1.9%. EARNEST Partners opened 13 new positions and exited 10, leaving the 1,185-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
- EARNEST Partners's largest Q2 2023 buy was TriNet: 1,113,592 shares worth $106M.
- EARNEST Partners added most to Helmerich & Payne in Q2 2023, an estimated $77.1M increase.
- EARNEST Partners's biggest Q2 2023 reduction was Syneos Health, Inc. Class A Common Stock, cutting an estimated $105M.
- EARNEST Partners fully exited ABB Ltd in Q2 2023, selling an estimated $373K.
- EARNEST Partners's ten largest holdings make up 15% of its $17.9B portfolio in Q2 2023.
- EARNEST Partners opened 13 new positions and closed 10 in Q2 2023.
- EARNEST Partners's portfolio value rose 3.5% quarter-over-quarter to $17.9B.
Based on EARNEST Partners's 13F filing for Q2 2023, filed 7 Aug 2023.